Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2019-12-25 2019-12-24
Drug Identification Number 02223252 02223252
Brand name PROCTOSEDYL PROCTOSEDYL
Common or Proper name Hydrocortisone, Framycetin, Cinchocaine, Aesculin Hydrocortisone, Framycetin, Cinchocaine, Aesculin
Company Name APTALIS PHARMA CANADA ULC APTALIS PHARMA CANADA ULC
Ingredients HYDROCORTISONE FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE ESCULIN
Strength(s) 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
Dosage form(s) OINTMENT OINTMENT
Route of administration RECTAL RECTAL
Packaging size 30g 30g
ATC code C05AA C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-06 2019-12-06
Estimated end date 2019-12-20 2019-12-20
Actual end date 2019-12-24 2019-12-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments